Evogene

EVGN

Evogene (NASDAQ:EVGN, TASE: EVGN.TA) is a leading computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. Incorporating a deep understanding of biology and leveraging Big Data and Artificial Intelligence.

Evogene has been a target of short sellers for a while. The current short interest of 0.47% is roughly at the average of the last 12 months (1.32%).